Nociception in cyclooxygenase isozyme-deficient mice

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Prostaglandins, synthesized by cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), are key mediators of hyperalgesia at sensory nerve endings.
• Understanding the distinct roles of COX-1 and COX-2 in pain processing is crucial for developing targeted analgesic therapies.

Purpose of the Study:

• To elucidate the specific contributions of COX-1 and COX-2 to pain sensation and analgesia.
• To investigate the compensatory mechanisms between COX-1 and COX-2 in response to genetic deficiency.

Main Methods:

• Utilized COX-1- or COX-2-deficient homozygous and heterozygous mice, alongside wild-type controls.
• Assessed nociception using the hot plate test (55°C) and the acetic acid-induced stretching test.
• Quantified messenger RNA (mRNA) levels of COX-1 and COX-2 in spinal cord tissue via reverse transcription-polymerase chain reaction (RT-PCR).

Main Results:

• COX-1-deficient heterozygous mice exhibited reduced nociception on the hot plate, indicated by longer reaction times.
• Both COX-1-null and COX-1-deficient heterozygous mice, as well as female COX-2-deficient heterozygotes, showed decreased nociception in the stretching test.
• Spinal cord analysis revealed compensatory upregulation of COX-1 mRNA in COX-2-null mice, but not vice versa.

Conclusions:

• COX-1 plays a predominant role in pain transmission, especially in the stretching test, for both sexes.
• COX-2 also contributes to pain signaling in the stretching test, with a notable role in females.
• Genetic deficiency in one COX enzyme may be compensated by the other, though these mechanisms are not fully symmetrical.